The percentages of participants who achieved weight reductions 5 % at two years were significantly higher in the moderate-dose ( 58 % ) and high-dose ( 58 % ) conditions compared with low-dose ( 43 % ) and control ( 40 % ) conditions ( posterior probability > 0.996 ) .